Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes

Diabetes

Volumn 51, Issue 5, 2002, Pages 1346-1355

  Graham, Jinko ^a   Hagopian, William A ^b   Kockum, Ingrid ^c   Li, Lou Sheng ^c   Sanjeevi, Carani B ^c   Lowe, Robert M ^d   Schaefer, Jonathan B ^d   Zarghami, Marjan ^d   Day, Heather L ^d   Landin Olsson, Mona ^e   Palmer, Jerry P ^d   Janer Villanueva, Marta ^f   Hood, Leroy ^f   Sundkvist, Göran ^g   Lernmark, Åke ^d   Breslow, Norman ^d   Dahlquist, Gisela ^h   Blohmé, Göran ⁱ  

^a SIMON FRASER UNIVERSITY   (Canada)

^b Paciflc Northwest Research Institute   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF WASHINGTON   (United States)

^e LUND UNIVERSITY   (Sweden)

^f INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^g LUND UNIVERSITY HOSPITAL   (Sweden)

^h UMEÅ UNIVERSITY   (Sweden)

ⁱ STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA DQ ANTIGEN; INSULIN; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ADULT; AGE; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GENETIC MARKER; HEREDITY; HLA TYPING; HUMAN; IMMUNOLOGICAL TOLERANCE; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; PANCREAS ISLET CELL; PRIORITY JOURNAL; SEX DIFFERENCE; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 0036319041     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.5.1346     Document Type: Article

References (51)

1. Male predominance of type 1 (insulin-dependent) diabetes mellitus in young adult: Results from a 5-year prospective nationwide study of the 15-34 year age group in Sweden
2. Incidence of childhood type 1 diabetes worldwide
3. Immunology in diabetes: An update
4. An overview of the genetic analysis of complex diseases, with reference to type 1 diabetes
5. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus
6. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus
7. The CTLA-4 gene region on chromosome 2q33 is linked to, and associated with type 1 diabetes
8. The length of the CTLA-4 microsatellite (AT)N-repeat affects the risk for type 1 diabetes
9. *0302 haplotype at clinical type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years
10. Islet cell and thyrogastric antibodies in 633 consecutive 15- to 34-yr-old patients in the Diabetes Incidence Study in Sweden
11. Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases
12. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma
13. Glutamate decarboxylase-, insulin- and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children
14. Associations of GAD65- and IA-2-autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings
15. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies
16. Concentration of insulin autoantibodies at onset of type I diabetes: Inverse log-linear correlation with age
17. Association study designs for complex diseases
18. * 0102 is attenuated with age at onset
19. Dominant protection and parental transmission of allele of the insulin gene-linked minisatellite locus
20. Statistical methods in cancer research. Volume I-the analysis of case-control studies
21. Predictive value of islet cell and insulin autoantibodies for type I (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children
22. Complex interaction between HLA DR and DQ in conferring risk for childhood type 1 diabetes
23. Polymorphic anuno acid variations in HLA-DQ are associated with systematic physical property changes and occurrence of IDDM
24. Insulin antibodies in insulin-dependent diabetics before insulin treatment
25. Increased specificity and sensitivity of insulin antibody measurements in autoimmune thyroid disease and type I diabetes
26. Insulin autoantibodies measured by radioinmmnoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: Results of the Fourth International Workshop on the Standardization of Insulin Autoantibody Measurement
27. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD-64) showed 64K autoantibody positivity at onset predicts diabetes type
28. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM
29. Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes
30. The World Health Organization International Collaborative Study for islet cell antibodies
31. Cloning and expression of IDDM-specific human autoantigens
32. Autoantibodies to protein tyrosine phosphatase-like protein in type 1 diabetes: Overlapping specificities to phogrin and ICA512/IA-2
33. Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in type 1 (insulin-dependent) diabetes mellitus
34. Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies
35. Screening for genetic IDDM risk and prevention trials in infancy
36. HLA and glutamic acid decarboxylase in human insulin-dependent diabetes mellitus
37. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase
38. Appearance of islet cell autoantibodies after clinical diagnosis of diabetes mellitus
39. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes
40. Association between autoantibody markers and subtypes of DR4 and DR4-DQ in Swedish children with insulin-dependent diabetes reveals closer association of tyrosine pyrophosphatase autoimmunity with DR 4 than DQS
41. HLA-DR3 is associated with a more slowly progressive form of type 1 (insulin-dependent) diabetes
42. Prospective study of predictors of beta-cell survival in type I diabetes
43. The insulin gene transcribed in the human thymus and transcription level correlate with allelic variation at the INS VNTR-IDDM 2 susceptibility locus for type 1 diabetes
44. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM 2 locus
45. CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers
46. CTLA-4 gene polymorphism correlates with the mode of onset and presence of ICA512 Ab in Japanese type 1 diabetes
47. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis
48. Genetic association of CTLA-4 to myasthenia gravis with thymoma